If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
IAEA-TECDOC-1605
English IAEA-TECDOC-1605 | 978-92-0-110608-7
60 pages | € 15.00 | Date published: 2008This publication is intended to assist health managers, nuclear medicine physicians and referring physicians involved in the management of cancer patients through further application of positron emission tomography (PET) technology. PET is currently used in conjunction with computed tomography (PET/CT), 18F-fluorodeoxyglucose (18F-FDG) and other radiopharmaceuticals to detect and target cancer more effectively within the body. Its clinical role could be expanded to include a number of other clinical scenarios such as the detection of occult cancers, preoperative staging of cancers, confirmation of suspected recurrences, radiation treatment planning and monitoring of patient response to therapy. This publication is a useful resource for specialists in nuclear medicine and in oncology,aiming to improve clinical management of cancer patients through these techniques.
More Information on reusing IAEA copyright material.
Orders and requests for information may also be addressed to:
Publishing Section
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
